These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 9830459

  • 1. Radiotherapy-induced emesis. An overview.
    Feyer P, Zimmermann JS, Titlbach OJ, Buchali A, Hinkelbein M, Budach V.
    Strahlenther Onkol; 1998 Nov; 174 Suppl 3():56-61. PubMed ID: 9830459
    [Abstract] [Full Text] [Related]

  • 2. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
    Jeremić B.
    Srp Arh Celok Lek; 1996 Nov; 124(5-6):131-4. PubMed ID: 9102832
    [Abstract] [Full Text] [Related]

  • 3. Radiation-induced emesis: effects of ondansetron.
    Scarantino CW, Ornitz RD, Hoffman LG, Anderson RF.
    Semin Oncol; 1992 Dec; 19(6 Suppl 15):38-43. PubMed ID: 1485181
    [Abstract] [Full Text] [Related]

  • 4. Prophylaxis versus treatment: is there a better way to manage radiotherapy-induced nausea and vomiting?
    Horiot JC.
    Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1018-25. PubMed ID: 15519770
    [Abstract] [Full Text] [Related]

  • 5. 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19).
    National Cancer Institute of Canada Clinical Trials Group (SC19)National Cancer Institute of Canada Clinical Trials Group, Canada. Rebecca.wong@rmp.uhn.on.ca, Wong RK, Paul N, Ding K, Whitehead M, Brundage M, Fyles A, Wilke D, Nabid A, Fortin A, Wilson D, McKenzie M, Ackerman I, Souhami L, Chabot P, Pater J.
    J Clin Oncol; 2006 Jul 20; 24(21):3458-64. PubMed ID: 16849762
    [Abstract] [Full Text] [Related]

  • 6. Optimising antiemetic therapy: what are the problems and how can they be overcome?
    Aapro M.
    Curr Med Res Opin; 2005 Jun 20; 21(6):885-97. PubMed ID: 15969889
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acute and delayed nausea and emesis control in pediatric oncology patients.
    Holdsworth MT, Raisch DW, Frost J.
    Cancer; 2006 Feb 15; 106(4):931-40. PubMed ID: 16404740
    [Abstract] [Full Text] [Related]

  • 17. Evidence-based recommendations for the use of antiemetics in radiotherapy.
    Maranzano E, Feyer PCh, Molassiotis A, Rossi R, Clark-Snow RA, Olver I, Warr D, Schiavone C, Roila F, Participants in the Perugia Consensus Conference 2004.
    Radiother Oncol; 2005 Sep 15; 76(3):227-33. PubMed ID: 16150504
    [Abstract] [Full Text] [Related]

  • 18. Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods.
    Mahesh R, Perumal RV, Pandi PV.
    Pharmazie; 2005 Feb 15; 60(2):83-96. PubMed ID: 15739895
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.